Literature DB >> 31848869

Continued Improvement in Rectal Cancer Survival Outcomes Will Require True Multidisciplinary Treatment Approaches.

Sonia Cohen1, Liliana Bordeianou2.   

Abstract

The management of rectal cancer has undergone a significant paradigm shift, with an increased interest in the utilization of all tools in our current armamentarium of fighting it: chemotherapy, radiotherapy and surgery. Research is also underway in deciding on the best sequence for these treatments. In this review, we provide an update on some of this important work.

Entities:  

Keywords:  Circumferential resection margin; Rectal cancer; Total mesorectal excision

Mesh：

Year:  2019        PMID： 31848869     DOI： 10.1007/s11605-019-04461-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


  25 in total

1.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

2.  Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

Authors:  Jean-François Bosset; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Antoine Briffaux; Laurence Collette
Journal:  J Clin Oncol       Date:  2005-07-11       Impact factor: 44.544

3.  Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 Trial.

Authors:  Philippe Rouanet; Eric Rullier; Bernard Lelong; Philippe Maingon; Jean-Jacques Tuech; Denis Pezet; Florence Castan; Stéphanie Nougaret
Journal:  Dis Colon Rectum       Date:  2017-07       Impact factor: 4.585

4.  No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT).

Authors:  Aldo Sainato; Valentina Cernusco Luna Nunzia; Vincenzo Valentini; Antonino De Paoli; Enrici Riccardo Maurizi; Marco Lupattelli; Cynthia Aristei; Cristiana Vidali; Monica Conti; Alessandra Galardi; Pietro Ponticelli; Maria Luisa Friso; Tiziana Iannone; Falchetto Mattia Osti; Bruno Manfredi; Marianna Coppola; Cinzia Orlandini; Luca Cionini
Journal:  Radiother Oncol       Date:  2014-11-14       Impact factor: 6.280

5.  Rectal Cancer, Version 2.2015.

Authors:  Al B Benson; Alan P Venook; Tanios Bekaii-Saab; Emily Chan; Yi-Jen Chen; Harry S Cooper; Paul F Engstrom; Peter C Enzinger; Moon J Fenton; Charles S Fuchs; Jean L Grem; Axel Grothey; Howard S Hochster; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Lucille A Leong; Edward Lin; Wells A Messersmith; Mary F Mulcahy; James D Murphy; Steven Nurkin; Eric Rohren; David P Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Kristina M Gregory; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2015-06       Impact factor: 11.908

6.  Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.

Authors:  A J Breugom; W van Gijn; E W Muller; Å Berglund; C B M van den Broek; T Fokstuen; H Gelderblom; E Kapiteijn; J W H Leer; C A M Marijnen; H Martijn; E Meershoek-Klein Kranenbarg; I D Nagtegaal; L Påhlman; C J A Punt; H Putter; A G H Roodvoets; H J T Rutten; W H Steup; B Glimelius; C J H van de Velde
Journal:  Ann Oncol       Date:  2014-12-05       Impact factor: 32.976

7.  Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.

Authors:  Carlos Fernández-Martos; Carles Pericay; Jorge Aparicio; Antonieta Salud; Mariajose Safont; Bertomeu Massuti; Ruth Vera; Pilar Escudero; Joan Maurel; Eugenio Marcuello; Jose Luis Mengual; Eugenio Saigi; Rafael Estevan; Moises Mira; Sonia Polo; Ana Hernandez; Manuel Gallen; Fernando Arias; Javier Serra; Vicente Alonso
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

9.  Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.

Authors:  Yu Jo Chua; Yolanda Barbachano; David Cunningham; Jacqui R Oates; Gina Brown; Andrew Wotherspoon; Diana Tait; Alison Massey; Niall C Tebbutt; Ian Chau
Journal:  Lancet Oncol       Date:  2010-01-25       Impact factor: 41.316

Review 10.  Sphincter-sparing surgery in patients with low-lying rectal cancer: techniques, oncologic outcomes, and functional results.

Authors:  Liliana Bordeianou; Lillias Holmes Maguire; Karim Alavi; Ranjan Sudan; Paul E Wise; Andreas M Kaiser
Journal:  J Gastrointest Surg       Date:  2014-05-13       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.